- Trials with a EudraCT protocol (40)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
40 result(s) found for: Cerebral Arteries.
Displaying page 1 of 2.
EudraCT Number: 2015-002721-18 | Sponsor Protocol Number: AC-054-203 | Start Date*: 2016-02-17 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | ||||||||||||||||||
Full Title: A prospective, multi-center, open-label, single-arm, Phase 2 study to assess the efficacy and safety of clazosentan in reversing angiographically-confirmed cerebral vasospasm in adult subjects with... | ||||||||||||||||||
Medical condition: Aneurysmal subarachnoid hemorrhage (aSAH); cerebral vasospasm | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001235-20 | Sponsor Protocol Number: 14.0189 | Start Date*: 2015-06-05 |
Sponsor Name:St George's University of London | ||
Full Title: Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease | ||
Medical condition: PARTICIPANTS WITH EVIDENCE OF CEREBRAL SMALL VESSEL DISEASE | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002457-30 | Sponsor Protocol Number: 13.0099 | Start Date*: 2013-09-13 | |||||||||||||||||||||
Sponsor Name:St George's University of London | |||||||||||||||||||||||
Full Title: An open label randomised controlled trial investigating the effect of donepezil on regional cerebral blood flow in adults with aneurysmal subarachnoid haemorrhage. | |||||||||||||||||||||||
Medical condition: Aneurysmal subarachnoid haemorrhage Cerebral vasospasm Ischaemic stroke | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000896-26 | Sponsor Protocol Number: ETLAS | Start Date*: 2016-05-19 | ||||||||||||||||
Sponsor Name:Herlev Gentofte Hospital | ||||||||||||||||||
Full Title: Effect of Tadalafil on cerebral large arteries in stroke patients. | ||||||||||||||||||
Medical condition: Stroke and small vessel disease. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001338-27 | Sponsor Protocol Number: 2014-001338-27 | Start Date*: 2014-06-19 |
Sponsor Name:Helsinki University Central hospital | ||
Full Title: Influence of propofol and desfluran on the cerebral circulation and recovery after anesthesia | ||
Medical condition: Carotid endarterectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002195-40 | Sponsor Protocol Number: CHOICE | Start Date*: 2018-10-31 |
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
Full Title: CHemical OptImization of Cerebral Embolectomy in patients with acute stroke treated with mechanical thrombectomy | ||
Medical condition: Cerebral Embolectomy in patients with acute stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000929-59 | Sponsor Protocol Number: MultiH/BRA/708 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Bracco ALTANA Pharma GmbH | |||||||||||||
Full Title: INTRAINDIVIDUAL CROSS-OVER STUDY TO COMPARE MULTIHANCE® AND MAGNEVIST® AT A DOSE OF 0.1 MMOL/KGBW IN CERVICO-CEREBRAL MR ANGIOGRAPHY AND CEREBRAL MR PERFUSION IMAGING AT 3 TESLA IN PATIENTS WITH CA... | |||||||||||||
Medical condition: Carotid artery stenosis and scheduled for MRA, for MR perfusion examination and for an elective stent treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002453-31 | Sponsor Protocol Number: AC-054-201 | Start Date*: 2005-02-15 |
Sponsor Name:Actelion Pharmaceuticals Ltd. | ||
Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem... | ||
Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-003238-35 | Sponsor Protocol Number: 4_141221 | Start Date*: 2021-09-15 | |||||||||||
Sponsor Name:Oslo University Hospital | |||||||||||||
Full Title: Effects of supplemental oxygen on systemic and cerebral hemodynamics in experimental hypovolemia: A randomized, phase IV, crossover study to study the effect of supplemental oxygen vs. room air on ... | |||||||||||||
Medical condition: Hypovolemia is the condition under investigation. Hypovolemia is induced by the "lower body negative pressure" (LBNP)-model. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003213-29 | Sponsor Protocol Number: SPh/02/2014 | Start Date*: 2015-03-02 | ||||||||||||||||
Sponsor Name:SciencePharma spółka z ograniczoną odpowiedzialnością sp. j. | ||||||||||||||||||
Full Title: A randomized, multicenter, open-label, two-arm, parallel, phase III study to evaluate the efficacy and safety of nicotinic acid administered in combination with simvastatin for 6 months in comparis... | ||||||||||||||||||
Medical condition: Inhibiting the progression of atherosclerosis in patients with carotid arteries stenosis and dyslipidemia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005539-14 | Sponsor Protocol Number: 12649A | Start Date*: 2008-11-25 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A randomised, double-blind, parallel-group, placebo-controlled phase III study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke. | |||||||||||||
Medical condition: Acute ischemic stroke within 3 - 9 hours after the onset of symptoms. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SE (Prematurely Ended) FI (Prematurely Ended) IE (Prematurely Ended) DK (Prematurely Ended) GB (Prematurely Ended) IT (Prematurely Ended) EE (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002760-41 | Sponsor Protocol Number: CL2-RTCCAR-001 | Start Date*: 2017-09-18 | |||||||||||
Sponsor Name:institute de Recherches Internacionales Servier (promotor internacional) | |||||||||||||
Full Title: Assessment of Active Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) plasma kinetics in Patients at acute stage of Ischemic Stroke: Prospective, Multicentre, Open, Non-randomised, Biomarker Study | |||||||||||||
Medical condition: Acute Ischemic Stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000622-40 | Sponsor Protocol Number: 12402A | Start Date*: 2009-01-21 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A randomised, double-blind, parallel-group, placebo-controlled phase III study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke. | |||||||||||||
Medical condition: Acute ischemic stroke within 3 - 9 hours after the onset of symptoms. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) HU (Completed) AT (Completed) DE (Prematurely Ended) FR (Completed) ES (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000868-15 | Sponsor Protocol Number: P001151 | Start Date*: 2019-01-15 | |||||||||||
Sponsor Name:Medical Center -University of Freiburg | |||||||||||||
Full Title: Stereotactic Cisternal Lavage in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention of Secondary Brain Injury. A Randomized Controlled Trial. | |||||||||||||
Medical condition: Aneurysmal Subarachnoid Hemorrhage (aSAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002798-50 | Sponsor Protocol Number: prostacyclin | Start Date*: 2011-09-27 | |||||||||||
Sponsor Name:Rune Rasmussen | |||||||||||||
Full Title: Effect of prostacyclin infusion on cerebral vessels and metabolism in patients with subarachnoid haemorrhage | |||||||||||||
Medical condition: Vasospasm following subarachnoid hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005254-24 | Sponsor Protocol Number: HA009 | Start Date*: 2008-01-14 | |||||||||||
Sponsor Name:Nuvelo, Inc | |||||||||||||
Full Title: PHASE 2, MULTICENTER, OPEN-LABEL, TWO-STAGE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRA-ARTERIAL CATHETER-DIRECTED ALFIMEPRASE FOR RESTORATION OF NEUROLOGIC FUNCTION AND RAPID OPENING OF ART... | |||||||||||||
Medical condition: Acute Ischemic Stroke (AIS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000981-12 | Sponsor Protocol Number: ALIROCKS_05MAR2018_V3 | Start Date*: 2018-05-11 |
Sponsor Name:Medical University of Graz | ||
Full Title: A PILOT STUDY INVESTIGATING THE EFFECTS OF LIPID-THERAPY INTENSIFICATION WITH ALIROCUMAB ON ENDOTHELIAL FUNCTION, CAROTID ARTERIES, LIPOPROTEIN PARTICLE SUBFRACTIONS, INFLAMMATION AND POST-PRANDIAL... | ||
Medical condition: Primary Hypercholesterolemia in secondary prevention after an acute atherosclerotic, ischaemic cardiovascular event for patients with diagnostically confirmed coronary heart disease and / or periph... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-000434-34 | Sponsor Protocol Number: UMCU-VASC-CO-003 | Start Date*: 2023-04-12 |
Sponsor Name:University Medical Centre Utrecht | ||
Full Title: A placebo-controlled, double-blind randomized trial evaluating the effect of etidronate in young patients with pseudoxanthoma elasticum on ectopic mineralization. | ||
Medical condition: Pseudoxanthoma elasticum | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003285-40 | Sponsor Protocol Number: 2019PI117 | Start Date*: 2020-12-15 | |||||||||||
Sponsor Name:CHRU de Nancy | |||||||||||||
Full Title: Evaluation of the hemodynamic tolerance of potassium canrenoate in brain-dead organ donors: randomized controlled clinical trial "CANREO-PMO" | |||||||||||||
Medical condition: hemodynamic of patients in a state of cerebral death candidate for renal or multiple organ removal (including kidney) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004565-14 | Sponsor Protocol Number: 20170625 | Start Date*: 2019-09-13 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardia... | |||||||||||||
Medical condition: Dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) HU (Trial now transitioned) DK (Trial now transitioned) DE (Trial now transitioned) PL (Trial now transitioned) BG (Ongoing) ES (Ongoing) PT (Trial now transitioned) FI (Trial now transitioned) AT (Trial now transitioned) LT (Ongoing) EE (Ongoing) SK (Trial now transitioned) GR (Ongoing) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.